Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019

BACKGROUND: Anti-vascular endothelial growth factor (anti-VEGF) medicines have revolutionized DME and DR treatment. Despite the worldwide use of anti-VEGFs, their use remains limited in Sudan. This study aimed to assess the impact of anti-VEGF (ranibizumab and bevacizumab) injections in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmedalgabri, Rayan Hamza Mohammed, Omer, Tarig, Zarroug, Fatima, Elkhawad, Abdullah Omer, Noma, Mounkaila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994601/
https://www.ncbi.nlm.nih.gov/pubmed/35411193
http://dx.doi.org/10.2147/CPAA.S338926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994601/
https://www.ncbi.nlm.nih.gov/pubmed/35411193
http://dx.doi.org/10.2147/CPAA.S338926

Ejemplares similares